Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00503022 |
This study evaluates the tolerability and safety of a single intravenous infusion of ACZ885. It also explores the efficacy of the compound in central macular edema and visual acuity in patients with wet age-related macular edema.
Condition | Intervention | Phase |
---|---|---|
Wet Age-Related Macular Degeneration |
Drug: ACZ885 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Masked, Multi-Center Phase I Study of 6 Months Duration to Assess the Safety and Tolerability of Intravenous ACZ885 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration |
Estimated Enrollment: | 20 |
Study Start Date: | July 2006 |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Inclusion criteria:
Exclusion criteria:
Switzerland | |
Bern, Switzerland | |
United Kingdom | |
Liverpool, United Kingdom | |
Nottingham,, United Kingdom | |
Bristol, United Kingdom | |
Southampton, United Kingdom | |
Wolverhampton, United Kingdom | |
Belfast, Northern Ireland, United Kingdom | |
London, United Kingdom |
Study Chair: | Novartis EH 001 862 778 8300 | COREC,UK |
Study ID Numbers: | CACZ885F2201 |
Study First Received: | July 17, 2007 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00503022 History of Changes |
Health Authority: | Switzerland: Swiss Agency for Therapeutic Products; United Kingdom: Medicine and Healthcare products Regulatory Agency (MHRA) |
Wet age-related macular degeneration ACZ885 |
Metaplasia Eye Diseases Choroid Diseases Neoplasm Metastasis Retinal Degeneration |
Macular Degeneration Neovascularization, Pathologic Retinal Diseases Choroidal Neovascularization |
Uveal Diseases Pathologic Processes Metaplasia Eye Diseases Choroid Diseases |
Retinal Degeneration Macular Degeneration Neovascularization, Pathologic Retinal Diseases Choroidal Neovascularization |